This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks That Could Rise in Market Decline

10. Baker Hughes (BHI - Get Report)

Company profile: Baker Hughes, with a market value of $18 billion, is a provider of a wide variety of oil-field services, such as directional drilling, oil field chemicals, drill bits, and electronic submersible pumping systems.

Dividend Yield: 1.4%

Investor takeaway: Its shares are down 15% this year, but have a three-year, average annual return of 11%. Analysts give its shares 13 "buy" ratings, nine "buy/holds," 11 "holds," and one "weak hold," according to a survey of analysts by S&P. Morningstar says its shares, now trading at $40.59, are trading at 46% of their fair-value estimate of $86.

9. AMN Healthcare Services (AHS)

Company profile: AMN Healthcare, with a market value of $248 million, is the largest health-care staffing firm in the U.S. About two-thirds of its business is generated from its temporary nursing division, but it also provides medical professionals of all ranks.

Investor takeaway: Its shares are up 41% this year, including 22% in the past month, and have a three-year, average annual return of 1%. Analysts give its shares three "buy" ratings and four "holds," according to a survey of analysts by S&P. Morningstar analyst Vishnu Lekraj says the company is in place to benefit long-term, from strong secular industry tailwinds. Morningstar says the shares, recently at $5.90, are trading at 45% of their fair-value estimate of $13.

8. Halliburton (HAL - Get Report)

Company profile: Halliburton, with a market value of $30 billion, provides a variety of oil-field services, from pressure pumping to drilling, across North America and about 80 countries.

Dividend Yield: 1.1%

Investor takeaway: Its shares are down 4.8% this year, but have a three-year, average annual return of 25%. Morningstar says its shares, now trading at $32.37, are trading at 45% of their fair-value estimate of $72. Analysts tracked by S&P give its shares 16 "buy" ratings, 13 "buy/holds," and four "holds," according to a survey of analysts by S&P.

7. GenOn Energy (GEN)

Company profile: GenOn Energy, with a market value of $1.5 billion, is an independent power producer operating in the Mid-Atlantic and Northeast regions and also in California. The company was formed by the result of the December, 2010 merger of RRI Energy and Mirant.

Investor takeaway: Its shares are down 22% this year and have a three-year, average annual loss of 19%. Morningstar says that its shares, now trading at $2, are trading at 44% of fair value of $4.50. Analysts give its shares five "buy" ratings, one "buy/holds," three "holds," and three "sells," according to a survey of analysts by S&P. S&P, which has it rated "buy" says the merger will result in geographic diversity and reduces its reliance on coal-fired assets.

6. Exelixis (EXEL - Get Report)

Company profile: Exelixis, with a market value of $754 million, is development-stage biotechnology company with a focus on therapeutics for the treatment of cancer and other serious diseases.

Investor takeaway: Its shares are up 7.3% this year and have a three-year, average annual return of 1.5%. Morningstar says its shares, now at $4.94, are trading at 44% of its fair-value estimate of $11. Analysts give its shares three "buy" ratings, one "buy/hold," and six "holds," according to a survey of analysts by S&P.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
BHI $67.65 -2.10%
EXEL $2.86 -2.70%
HAL $48.04 -2.40%
NRG $25.11 -1.60%
PTEN $21.54 -2.90%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs